Showing results (561-570 of 1,006) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|November 28, 2008
Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemiaGary J Grover, Johan MalmCardiovascular Therapeutics|November 28, 2008
Liver X receptors (LXR) as therapeutic targets in dyslipidemiaJerzy BełtowskiCardiovascular Therapeutics|August 20, 2009
Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapyLawrence A Notaro, Mohammed H Usman, James F Burke, et al.Cardiovascular Therapeutics|April 22, 2010
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trialKarl Andersen, Myron H Weinberger, Brent Egan, et al.Cardiovascular Therapeutics|April 22, 2010
Drug-induced hERG block and long QT syndromeHarry J WitchelCardiovascular Therapeutics|October 17, 2009
Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditionsStefano Omboni, Ettore Malacco, Gianfranco ParatiCardiovascular Therapeutics|August 27, 2016
Clinical and economic outcomes among elderly myocardial infarction survivors in the United StatesErru Yang, Michael Stokes, Saga Johansson, et al.Cardiovascular Therapeutics|August 28, 2016
Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrelHong-Hui Yang, Yan Chen, Chuan-Yu GaoCardiovascular Therapeutics|September 24, 2016
Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluationRainer Zbinden, Stefanie von Felten, Bastian Wein, et al.Pageof 101